Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.22 is 87% above its 5-year average of -1.70, near the high end of its 5-year range (-3.37–-0.15).
80.44% above its 12-month average of -1.13.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.31.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 37 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:22:38.824Z. Historical observations retain their original dates. Historical series through 2024-03-07.
EARNINGS PER SHARE (EPS)
-0.22
EARNINGS PER SHARE (EPS) AVG TTM
-1.13
EARNINGS PER SHARE (EPS) AVG 3Y
-1.09
EARNINGS PER SHARE (EPS) AVG 5Y
-1.70
EARNINGS PER SHARE (EPS) AVG 10Y
-1.85
EARNINGS PER SHARE (EPS) AVG 15Y
-1.40
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+80.44%
CURRENT VS 3Y AVG
+79.77%
CURRENT VS 5Y AVG
+87.05%
CURRENT VS 10Y AVG
+88.14%
CURRENT VS 15Y AVG
+84.27%
CURRENT VS 20Y AVG
N/A
MacroGenics, Inc.
Market Cap
$231.37M
Earnings Per Share (EPS)
-0.22
TTM Avg
-1.13
3Y Avg
-1.09
5Y Avg
-1.70
Market Cap
$230.37M
Earnings Per Share (EPS)
-3.17
TTM Avg
-5.64
3Y Avg
-13.77
5Y Avg
-18.37
Market Cap
$228.72M
Earnings Per Share (EPS)
-2.38
TTM Avg
-2.11
3Y Avg
-1.81
5Y Avg
-1.81
Market Cap
$236.33M
Earnings Per Share (EPS)
-0.04
TTM Avg
0.58
3Y Avg
0.64
5Y Avg
0.70
Market Cap
$235.67M
Earnings Per Share (EPS)
-0.57
TTM Avg
-0.79
3Y Avg
-0.77
5Y Avg
-0.98
Market Cap
$236.42M
Earnings Per Share (EPS)
-0.11
TTM Avg
-0.18
3Y Avg
-0.30
5Y Avg
-0.87
Market Cap
$237.90M
Earnings Per Share (EPS)
-0.39
TTM Avg
-0.86
3Y Avg
-1.43
5Y Avg
-1.56
Market Cap
$237.25M
Earnings Per Share (EPS)
-0.28
TTM Avg
-0.24
3Y Avg
-0.42
5Y Avg
-0.45
Market Cap
$224.93M
Earnings Per Share (EPS)
-0.99
TTM Avg
-1.25
3Y Avg
-1.31
5Y Avg
-1.33
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MacroGenics, Inc. (MGNX) | $231.37M | -0.22 | -1.13 | -1.09 | -1.70 |
| Biodesix, Inc. (BDSX)vs › | $230.37M | -3.17 | -5.64 | -13.77 | -18.37 |
| BioAge Labs Inc. (BIOA)vs › | $228.72M | -2.38 | -2.11 | -1.81 | -1.81 |
| SIGA Technologies, Inc. (SIGA)vs › | $236.33M | -0.04 | 0.58 | 0.64 | 0.70 |
| InflaRx N.V. (IFRX)vs › | $235.67M | -0.57 | -0.79 | -0.77 | -0.98 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $236.42M | -0.11 | -0.18 | -0.30 | -0.87 |
| Invivyd, Inc. (IVVD)vs › | $237.90M | -0.39 | -0.86 | -1.43 | -1.56 |
| High Tide Inc. (HITI)vs › | $237.25M | -0.28 | -0.24 | -0.42 | -0.45 |
| Profound Medical Corp. (PROF)vs › | $224.93M | -0.99 | -1.25 | -1.31 | -1.33 |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $237.97M | -0.45 | -0.52 | -0.50 | -0.51 |
Trailing EPS (TTM)
$-0.22
Forward EPS (Est.)
$-1.76
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.18 |
| 2024-12-31 | -1.07 |
| 2023-12-31 | -0.15 |
| 2022-12-31 | -1.95 |
| 2021-12-31 | -3.37 |
| 2020-12-31 | -2.47 |
| 2019-12-31 | -3.16 |
| 2018-12-31 | -4.19 |
| 2017-12-31 | -0.54 |
| 2016-12-31 | -1.69 |
| 2015-12-31 | -0.63 |
| 2014-12-31 | -1.40 |
| 2013-12-31 | -0.01 |
| 2012-12-31 | 0.46 |
| 2011-12-31 | 0.37 |
